A61K 47/555
Pre-targeting systems involving an organic compound, other than a peptide, protein or
Official title: {pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells}
A61K47/555 (Pre-targeting systems involving an organic compound, other than a peptide, protein or) appears on 361 US grants and 576 published applications in this corpus.
Search patents in A61K- Granted patents
- 361
- Published applications
- 576
- Assignees
- 319
- Inventors
- 1,129
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 4 | 0 |
| 1997 | 9 | 0 |
| 1998 | 10 | 0 |
| 1999 | 8 | 0 |
| 2000 | 5 | 0 |
| 2001 | 5 | 2 |
| 2002 | 10 | 14 |
| 2003 | 9 | 21 |
| 2004 | 7 | 19 |
| 2005 | 4 | 13 |
| 2006 | 6 | 22 |
| 2007 | 9 | 8 |
| 2008 | 4 | 16 |
| 2009 | 11 | 13 |
| 2010 | 9 | 27 |
| 2011 | 8 | 26 |
| 2012 | 10 | 10 |
| 2013 | 13 | 20 |
| 2014 | 16 | 14 |
| 2015 | 8 | 25 |
| 2016 | 12 | 23 |
| 2017 | 8 | 20 |
| 2018 | 19 | 32 |
| 2019 | 23 | 45 |
| 2020 | 20 | 33 |
| 2021 | 24 | 32 |
| 2022 | 22 | 37 |
| 2023 | 17 | 25 |
| 2024 | 21 | 27 |
| 2025 | 9 | 25 |
| 2026 | 12 | 27 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Chemically cleavable group15 Sep 2026US 12,735,444 B2Tagworks Pharmaceuticals B.V.
- Degraders of cyclin-dependent kinase 12 (CDK12) and uses thereof23 Jun 2026US 12,662,464 B2Dana-Farber Cancer Institute, Inc.
- Compounds for fast and efficient click release16 Jun 2026US 12,653,914 B2Tagworks Pharmaceuticals B.V.
- Microbubble-chemotherapeutic agent complex for sonodynamic therapy26 May 2026US 12,636,379 B2Sonotarg Limited
- Bioorthogonal compositions28 Apr 2026US 12,611,461 B2Tambo, Inc.
- Universal abt compounds and uses thereof24 Sep 2026US 2026/0284204 A1Kleo Pharmaceuticals, Inc.
- Modified biotin-binding protein, fusion proteins thereof and applications10 Sep 2026US 2026/0265313 A1Children's Medical Center Corporation
- Cd4 + and cd8 + single positive t cells and compositions and methods for generating the same20 Aug 2026US 2026/0242728 A1Clade Therpaeutics, Inc.
- Cytotoxicity targeting chimeras for antibody-drug conjugates and bispecific antibodies13 Aug 2026US 2026/0232834 A1GlaxoSmithKline Intellectual Property Development Limited
- Reversible covalent protein-binding molecules, methods of making and uses thereof6 Aug 2026US 2026/0224717 A1McMaster University
Most cited
By later US patents
- Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof518US 5,550,111 ATemple University of the Commonwealth System of Higher Education · 1996
- Method for enhancing transmembrane transport of exogenous molecules352US 5,416,016 APurdue Research Foundation · 1995
- Method for enhanced transmembrane transport of exogenous molecules302US 5,108,921 APurdue Research Foundation · 1992
- System for targeted delivery of therapeutic agents127US 8,709,483 B2Massachusetts Institute of Technology · 2014
- Pretargeting methods and compounds125US 6,217,869 B1NeoRx Corporation · 2001